NL-OMON55147已完成不适用
Distribution, dosimetry and imaging of [195mPt]cisplatin in cancer patients - [195mPt]cisplatin imaging
Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 6 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- > 18 years of age.
- •- Diagnosed with NSCLC.
- •- Planned for concurrent radiotherapy with cisplatin.
- •- At least one pulmonary tumour lesion of at least 3 cm over the longest axis.
排除标准
- •- Not able to provide informed consent.
- •- Pregnant or breastfeeding.
- •- Previous treatment with platinum compounds.
- •- Claustrophobia.
- •- eGFR < 60 ml/min.
研究者
相似试验
尚未招募
1 期
Role of radio-labelled GCC-compounds in diagnosis and treatment planning of colorectal cancerCTRI/2022/11/047568All India Institute of Medical Sciences, New Delhi
已完成
1 期
PK in Pts With HRPC & Skeletal MetastesProstatic NeoplasmsNCT00667537Bayer6
招募中
1 期
Comparison of Al18F-NOTA-LM3 With 68Ga-DOTATATE and 68Ga-NODAGA-LM3 PET/CT in Patients With Well-differentiated Neuroendocrine TumorsNeuroendocrine TumorsNCT06056362Peking Union Medical College Hospital80
已完成
不适用
Biodistribution and dosimetry of the newly developed P-gp PET tracer [11C]laniquidar in healthy volunteersNL-OMON35158Vrije Universiteit Medisch Centrum6
Unknown
早期 1 期
68Ga-BNOTA-PRGD2 PET/CT in Healthy Volunteers and Lung Cancer PatientsLung CancerNCT01527058Peking Union Medical College Hospital100